If you want a price and delivery time for a product, please click here
If you want a call back from an Aposave representative, please click here
If you want to book a meeting with Aposave at the EAHP 2021 Congress, please click here
If you want a product list, please click here
With a large stock of oncology, haematology and other ‘high-demand’ medicines held in our global distribution centre, Aposave is launching a new unlicensed medicine service: Individual Access Requests (IAR)
The name Individual Access Requests recognises that for every unlicensed medicine request, there is a patient in great need to access their medication.
The Aposave IAR has been created to give healthcare professionals and patients the highest quality products and service with exceptional prices. From now until the end of 2020, if you can find a better price from another supplier, we will price match it.
The Aposave IAR service is unique due to the combination of Aposave and parent company Abacus Medicine. Aposave provides global regulatory know-how, compliance and transparency.
Abacus Medicine has one of the most refined sourcing departments in the industry with ground-breaking data analytics. Together this means that the Aposave IAR offers you and your patients a new generation of unlicensed medicine service with speed, access and responsiveness.